Dive into the latest European updates from the FLASH Registry and gain insights into the importance of controlled randomised trials like PEERLESS and PEERLESS II. Join Prof Felix Mahfoud from Saarland University Hospital (Germany) in this educational video as he shares his approach to risk stratification for Intermediate-High pulmonary embolism (PE) patients. Discover the significance of prevention from normotensive shock and learn how to better assess and identify patients on the edge of deterioration, potentially benefiting from interventional treatment.